Fibrosis: all 1,270 studies
Page 11 of 13. Open to participants first (276), then studies with results posted, then the rest; newest registration first within each.
- Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in CirrhosisStatus unknownNCT01820026Phase 4
- Angiogenesis and Fibrosis in Myocardial InfarctionCompletedNCT01813045
- Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)CompletedNCT01810458
- Evaluating Ultrasound, Elastometry, Minilaparoscopy and Histology for the Diagnosis of Compensated Liver Cirrhosis.Status unknownNCT01807013
- Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side EffectsWithdrawnNCT01801228Phase 2
- Effects of Aerobic Training on Exercise Capacity in Patients With CirrhosisCompletedNCT01799785Not applicable
- Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic PatientsCompletedNCT01798173Not applicable
- Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109CompletedNCT01780077Phase 1
- The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in CirrhosisWithdrawnNCT01777971
- Comparative Analysis of Different Tests to Evaluate Prognosis of Patients on Liver Transplant Waiting ListCompletedNCT01774617
- Resting Energy Expenditure in Patients on the Waiting List for Liver TransplantationCompletedNCT01761851
- Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary HypertensionCompletedNCT01729611
- L-ornithine L-aspartate in Overt Hepatic EncephalopathyCompletedNCT01722578Phase 4
- Subclinical Myocardial Dysfunction in Patients With Hepatic CirrhosisCompletedNCT01713478Not applicable
- Biomarkers for the Prognosis of Decompensated Alcoholic Liver DiseaseCompletedNCT01701687
- VSL#3 and Spontaneous Bacterial PeritonitisTerminatedNCT01701297Phase 2
- Role of Fibrocytes in the Bronchial Remodelling of Chronic Obstructive Pulmonary DiseaseCompletedNCT01692444Not applicable
- Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With CirrhosisCompletedNCT01686698Phase 4
- Metoprolol Succinate in Cardiac Remodeling Related to CirrhosisCompletedNCT01676285Phase 3
- Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical PatientsStatus unknownNCT01669044
- Hepatocellular Carcinoma Growth and Molecular AggressivenessCompletedNCT01657695
- Effect of High-protein High-fiber Diet in Patients With Autoimmune HepatitisCompletedNCT01655121Not applicable
- Fibrosis a New Pathological Actor in Adipose TissueCompletedNCT01655017Not applicable
- Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)CompletedNCT01644656Not applicable
- Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109CompletedNCT01640912Phase 1
- Relative-dose-response Test (RDR) Adaptation for Chronic Liver DiseaseCompletedNCT01634698Not applicable
- ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis BStatus unknownNCT01633554
- Oxidative Stress and Haemostasis Abnormalities in CirrhosisStatus unknownNCT01607814
- Bioelectrical Impedance Vector Analysis in Cirrhotic PatientsCompletedNCT01603953
- Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver TransplantStatus unknownNCT01603108Phase 2
- The Effects of Spironolactone on Calcineurin Inhibitor Induced NephrotoxicityCompletedNCT01602861Phase 4
- Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver CirrhosisCompletedNCT01591200Phase 2
- Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal FailureWithdrawnNCT01587222Phase 2
- Procalcitonin in Cirrhotic Patients at High Risk for SepsisCompletedNCT01578226
- Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial HepatectomyCompletedNCT01562821Phase 2
- Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic EncephalopathyCompletedNCT01559519Phase 4
- Effect of Tolvaptan on Cognitive Function in CirrhosisCompletedNCT01556646Phase 3
- Esophageal Capsule Endoscopy in ChildrenCompletedNCT01551966Not applicable
- A Safety and Tolerability Study OF PUR118 In Subjects With Cystic FibrosisCompletedNCT01543191Phase 1
- Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume AnalyzerCompletedNCT01542749
- Absence of Steroid in Renal Transplantation and Digital Fibrosis ObservationCompletedNCT01541176Phase 4
- Evaluation of Innovative Ultrasonic Techniques for Non-invasive Diagnosis of Liver Fibrosis in Patients With Chronic Viral Hepatitis B or CCompletedNCT01537965Not applicable
- Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic ResponseStatus unknownNCT01530711Phase 4
- HIV Accelerated Liver Disease in UgandaCompletedNCT01524562
- Telaprevir Open-Label Study in Co-Infected PatientsCompletedNCT01500616Phase 3
- Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative TreatmentStatus unknownNCT01492127Not applicable
- Major RF Ablations of Hepatomas Under MR Thermometry MonitoringTerminatedNCT01486134Not applicable
- Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver CirrhosisStatus unknownNCT01483248Phase 1/2
- Prognostic Indicators as Provided by the EPIC ClearViewCompletedNCT01476995
- Vitamin E Supplement in Patients With Cirrhosis and AcanthocytosisCompletedNCT01463735Phase 2
- INR-Triggered Transfusion In GI Bleeders From ERTerminatedNCT01461889Phase 3
- Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial PeritonitisTerminatedNCT01455246Phase 2/3
- Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With PioglitazoneCompletedNCT01454336Phase 1
- Pilot Study of Simtuzumab in the Treatment of Liver FibrosisCompletedNCT01452308Phase 2
- Mechanisms Involved in the Benefits of an Exercise Programme in Patients With CirrhosisCompletedNCT01447537Not applicable
- Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of BiomarkersStatus unknownNCT01442350
- Transient Elastography in Hepatectomy for Hepatocellular CarcinomaStatus unknownNCT01441453Not applicable
- Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal BleedingCompletedNCT01434108Phase 2/3
- Mesenchymal Stem Cells After Renal or Liver TransplantationCompletedNCT01429038Phase 1/2
- Conservative Treatment Versus Elective Repair of Umbilical Hernia in Patients With Ascites and Liver CirrhosisStatus unknownNCT01421550Phase 3
- Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and CirrhosisCompletedNCT01409356Phase 2
- Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in CirrhosisCompletedNCT01408966Phase 2
- Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through DownstagingCompletedNCT01387503Not applicable
- Resection for Multiple Hepatocellular Carcinomas (HCC)CompletedNCT01387061Not applicable
- Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver FailureCompletedNCT01383460Phase 3
- Advance Care Planning Evaluation in Hospitalized Elderly PatientsCompletedNCT01362855
- A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary FibrosisCompletedNCT01362231Phase 1
- Albumin Administration in Cirrhotic Patients With Bacterial Infection and a Systemic Inflammatory Response Syndrome Unrelated to Spontaneous Bacterial PeritonitisTerminatedNCT01359813Phase 3
- Functional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT ScanStatus unknownNCT01350726
- Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver DiseaseStatus unknownNCT01350167Not applicable
- Mechanism and the Effect of Midodrine on Portal Pressures in Patients With CirrhosisWithdrawnNCT01331785Not applicable
- HIV Liver Regeneration Project for HIV Patients With Cirrhosis by Autologous Bone Marrow TransplantationStatus unknownNCT01309594Not applicable
- International Myocarditis RegistryStatus unknownNCT01307735
- Assessment of Endothelial Function, Apolipoproteins and AdiponectinCompletedNCT01300390
- Study on Immunopathogenesis in HIV and Hepatitis C CoinfectionCompletedNCT01296529
- Human Albumin for the Treatment of Ascites in Patients With Hepatic CirrhosisCompletedNCT01288794Phase 4
- Acoustic Radiation Force Impulse (ARFI)Technology in Prediction of Liver FibrosisStatus unknownNCT01268865
- Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced FibrosisCompletedNCT01268202Phase 2
- A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal BleedingCompletedNCT01267669Not applicable
- Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01266135Phase 2
- Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic HepatopathyStatus unknownNCT01246388
- Self-expandable Esophageal Stent Versus Balloon Tamponade in Refractory Esophageal Variceal Bleeding.CompletedNCT01242280Phase 3
- Renal Allograft : Evaluation of Parenchymal Fibrosis by ElastographyStatus unknownNCT01234363Not applicable
- Examination of Left Atrial Fibrosis Using MRIWithdrawnNCT01233674
- Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies.CompletedNCT01231828Not applicable
- Utility of Renal Biomarkers in CirrhosisCompletedNCT01217983
- Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar CarcinomaTerminatedNCT01215565Phase 2
- Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic UltrasoundCompletedNCT01208311
- ¹³C-Methacetin Breath Test (MBT) Methodology StudyStatus unknownNCT01205074Phase 2/3
- A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01203943Phase 2
- Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"CompletedNCT01201720Not applicable
- Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT01198704
- Early Primary Prophylaxis of Esophageal VaricesCompletedNCT01196507Not applicable
- Carvedilol + VSL#3 Versus Endoscopic Variceal Ligation for Primary Prophylaxis of Esophageal Variceal Bleeding in Cirrhotic Patients Non Responder to Carvedilol.CompletedNCT01196481Not applicable
- Diagnostic of Spontaneous Bacterial PeritonitisCompletedNCT01193426
- Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With CirrhosisCompletedNCT01188733Phase 1/2
- The Fibrosis-Lymphedema Continuum in Head and Neck CancerCompletedNCT01187173
- Short Term Feeding for Asian Patients With Liver CirrhosisCompletedNCT01165073Not applicable
- Sensitivity of Alternative NRL972 Detection Methods in Healthy SubjectsCompletedNCT01164332Phase 1
- Noninvasive Imaging of Heart Failure: A Pilot StudyCompletedNCT01160471